Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Checkmate

'Absolutely false': Electoral commission rubbishes United Australia Party claim that millions failed to vote

The UAP has emailed its members to claim the "highest number of people" in a century failed to turn out to vote at the federal election. It's one of dozens of claims the AEC has responded to since the polls closed.

ABC News

We looked into the lobby group taking on rugby star turned would-be senator David Pocock. Here's what we found

Conservative lobby group Advance Australia has independent ACT Senate candidate David Pocock in its sights, with Facebook advertising data revealing that the group's offensive against the former rugby star is disproportionate to its campaigning against any other candidate.

ABC News

'This is not a death tax': Coalition claims on Labor housing scheme fall flat with experts

Aspects of Labor's newly unveiled affordable housing scheme have been likened to a "death tax", but tax specialists have shot down those suggestions.

ABC News

From analysis to the latest developments in health,
read the most diverse news in one place.

A footy legend said 'heart issues and Bell's palsy has gone through the roof since the boosters'. Is he correct?

Despite what AFL legend Matthew Lloyd has claimed, there is no evidence to suggest heart issues "have gone through the roof" as a result of COVID-19 vaccines.

ABC News

The Prime Minister's failure to establish a federal ICAC looks like a broken promise

The Prime Minister blamed a lack of "bipartisan support" for his government's failure to establish a federal anti-corruption body. But the evidence suggests it's a broken promise.

ABC News

The Daily Biotech Pulse: Regeneron Acquires Checkmate Pharma, Moderna's Bivalent Booster COVID-19 Vaccine Update, Priority Review For AstraZeneca's Enhertu

Here's a roundup of top developments in the biotech space over the last 24 hours.

Benzinga

Checkmate Pharma Shares Skyrocket Over 300% On Regeneron $250M Acquisition Deal

Regeneron Pharmaceuticals Inc (NASDAQ:REGN) will acquire Checkmate Pharmaceuticals Inc (NASDAQ:CMPI) for $10.50 per share, equivalent to a total equity value of approximately $250 million. Checkmate is a clinical-stage biopharmaceutical company focused on proprietary technology to harness the immune system's power to combat cancer. The offer price represents a whopping premium of over 300% on…

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Why Checkmate Pharmaceuticals Shares Are Skyrocketing

Checkmate Pharmaceuticals Inc (NASDAQ: CMPI) shares are trading higher by 328.40% to $10.41 during Tuesday's pre-market session after Regeneron Pharmaceuticals Inc (NASDAQ: REGN) announced a deal to acquire the comp

Benzinga

We trawled through thousands of comments on the Prime Minister's Facebook page about flood victims. Here's what we didn't find

Did Australians use the PM's Facebook page to advocate for less government support for flood victims? We looked through thousands of comments — and found hardly any.

ABC News

Armed children in every Aussie school? Bob Katter misses the mark with gun claim

The independent MP has a novel idea for protecting the country from potential foreign threats: give children guns. Experts say the background to his claim gets our history wrong.

ABC News

A viral meme claims 35.5 per cent of Australian seniors live in relative poverty. Here's why it's bunkum

A years-old meme comparing the poverty rate for Australians aged over 65 to rates in other OECD countries has resurfaced, as cost of living concerns dominate federal election coverage. But its data is out-of-date, and its methodology is lacking.

ABC News

1 2 3

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.